Isoliquiritigen enhances the antitumour activity and decreases the genotoxic effect of cyclophosphamide

Molecules

Volumn 18, Issue 8, 2013, Pages 8786-8798

  Zhao, Hong ^a   Yuan, Xuan ^b   Li, Defang ^a   Chen, Hongmei ^a   Jiang, Jiangtao ^a   Wang, Zhiping ^b   Sun, Xiling ^c   Zheng, Qiusheng ^a,d  

^a SHIHEZI UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

^c BINZHOU MEDICAL UNIVERSITY   (China)

^d YANTAI UNIVERSITY   (China)

Author keywords

Antitumour; Cyclophosphamide; Genotoxic effect; Isoliquiritigenin

Indexed keywords

ANTINEOPLASTIC AGENT; CHALCONE DERIVATIVE; CYCLOPHOSPHAMIDE; ISOLIQUIRITIGENIN;

ANIMAL; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CHEMISTRY; DNA DAMAGE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ERYTHROCYTE; FEMALE; HUMAN; MOUSE; PATHOLOGY; UTERINE CERVIX TUMOR; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; TOXICITY; UTERINE CERVICAL NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CELL PROLIFERATION; CHALCONES; CYCLOPHOSPHAMIDE; DNA DAMAGE; ERYTHROCYTES; FEMALE; HUMANS; MICE; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84883157630     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18088786     Document Type: Article

References (52)

1. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69-90.
2. Attar, E.C.; Ervin, T.; Janicek, M.; Deykin, A.; Godleski, J. Side effects of chemotherapy. Case 3. Acute interstitial pneumonitis related to gemcitabine. J. Clin. Oncol. 2000, 18, 697-698.
3. Kerbel, R.S.; Kamen, B.A. The anti-angiogenic basis of metronomic chemotherapy. Nat. Rev. Cancer 2004, 4, 423-436.
4. Hanafelt, T.D.; Lin, T.; Geyer, S.M.; Zent, C.S.; Leung, N.; Kabat, B.; Bowen, D.; Grever, M.R.; Byrd, J.C.; Kay, N.E. Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia. Cancer 2007, 109, 2291-2298.
5. Perroud, H.A.; Rico, M.J.; Alasino, C.M.; Queralt, F.; Mainetti, L.E.; Pezzotto, S.M.; Rozados, V.R.; Scharovsky, O.G. Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients. Future Oncol. 2013, 9, 451-462.
6. Lebeau, B.; Chouaid, C.; Baud, M.; Masanes, M.J.; Febvre, M. Oral second- and third-line lomustine-etoposide-cyclophosphamide chemotherapy for small cell lung cancer. Lung Cancer 2010, 67, 188-193.
7. Hoffman, M.S.; Roberts, W.S.; Bryson, S.C.; Kavanagh, J.J., Jr.; Cavanagh, D.; Lyman, G.H. Treatment of recurrent and metastatic cervical cancer with cis-platin, doxorubicin, and cyclophosphamide. Gynecol. Oncol. 1988, 29, 32-36.
8. Oki, Y.; Ogura, M.; Kato, H.; Kikuchi, A.; Taji, H.; Kagami, Y.; Oshiro, A.; Tsujimura, A.; Yamamoto, K.; Morishima, Y. Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. Cancer Sci. 2008, 99, 179-184.
9. Meistrich, M.L.; Wilson, G.; Brown, B.W.; da Cunha, M.F.; Lipshultz, L.I. Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas. Cancer 1992, 70, 2703-2712..
10. Franke, S.I.; Pra, D.; da Silva, J.; Erdtmann, B.; Henriques, J.A. Possible repair action of vitamin C on DNA damage induced by methyl methanesulfonate, cyclophosphamide, FeSO4 and CuSO4 in mouse blood cells in vivo. Mutat. Res. 2005, 583, 75-84.
11. Rehman, M.U.; Tahir, M.; Ali, F.; Qamar, W.; Lateef, A.; Khan, R.; Quaiyoom, A.; Oday, O.H.; Sultana, S. Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: The protective effect of Ellagic acid. Mol. Cell Biochem. 2012, 365, 119-127.
12. Zhang, Q.H.; Wu, C.F.; Duan, L.; Yang, J.Y. Protective effects of ginsenoside Rg(3) against cyclophosphamide-induced DNA damage and cell apoptosis in mice. Arch. Toxicol. 2008, 82, 117-123.
13. Fintelmann, V. Modern phytotherapy and its uses in gastrointestinal conditions. Planta Med. 1991, 57, S48-S52.
14. Kamei, J.; Saitoh, A.; Asano, T.; Nakamura, R.; Ichiki, H.; Iiduka, A.; Kubo, M. Pharmacokinetic and pharmacodynamic profiles of the antitussive principles of Glycyrrhizae radix (licorice), a main component of the Kampo preparation Bakumondo-to (Mai-men-dong-tang). Eur. J. Pharmacol. 2005, 507, 163-168.
15. Haggag, E.G.; Abou-Moustafa, M.A.; Boucher, W.; Theoharides, T.C. The effect of a herbal water-extract on histamine release from mast cells and on allergic asthma. J. Herb. Pharmacother. 2003, 3, 41-54.
16. Fukai, T.; Satoh, K.; Nomura, T.; Sakagami, H. Preliminary evaluation of antinephritis and radical scavenging activities of glabridin from Glycyrrhiza glabra. Fitoterapia 2003, 74, 624-629.
17. Yokota, T.; Nishio, H.; Kubota, Y.; Mizoguchi, M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res. 1998, 11, 355-361.
18. Inoue, H.; Saito, H.; Koshihara, Y.; Murota, S. Inhibitory effect of glycyrrhetinic acid derivatives on lipoxygenase and prostaglandin synthetase. Chem. Pharm. Bull. (Tokyo) 1986, 34, 897-901.
19. Zhou, S.; Koh, H.L.; Gao, Y.; Gong, Z.Y.; Lee, E.J. Herbal bioactivation: The good, the bad and the ugly. Life Sci. 2004, 74, 935-968.
20. Haraguchi, H.; Ishikawa, H.; Mizutani, K.; Tamura, Y.; Kinoshita, T. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg. Med. Chem. 1998, 6, 339-347.
21. Tawata, M.; Aida, K.; Noguchi, T.; Ozaki, Y.; Kume, S.; Sasaki, H.; Chin, M.; Onaya, T. Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. Eur. J. Pharmacol. 1992, 212, 87-92.
22. Tamir, S.; Eizenberg, M.; Somjen, D.; Izrael, S.; Vaya, J. Estrogen-like activity of glabrene and other constituents isolated from licorice root. J. Steroid Biochem. Mol. Biol. 2001, 78, 291-298.
23. Chowdhury, S.A.; Kishino, K.; Satoh, R.; Hashimoto, K.; Kikuchi, H.; Nishikawa, H.; Shirataki, Y.; Sakagami, H.; Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Res. 2005, 25, 2055-2063.
24. Zhou, G.S.; Song, L.J.; Yang, B. Isoliquiritigenin inhibits proliferation and induces apoptosis of U87 human glioma cells in vitro. Mol. Med. Rep. 2013, 7, 531-536.
25. Kim, D.C.; Ramachandran, S.; Baek, S.H.; Kwon, S.H.; Kwon, K.Y.; Cha, S.D.; Bae, I.; Cho, C.H. Induction of growth inhibition and apoptosis in human uterine leiomyoma cells by isoliquiritigenin. Reprod. Sci. 2008, 15, 552-558.
26. Takahashi, T.; Takasuka, N.; Iigo, M.; Baba, M.; Nishino, H.; Tsuda, H.; Okuyama, T. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci. 2004, 95, 448-453.
27. Jung, J.I.; Chung, E.; Seon, M.R.; Shin, H.K.; Kim, E.J.; Lim, S.S.; Chung, W.Y.; Park, K.K.; Park, J.H. Isoliquiritigenin (ISL) inhibits ErbB3 signaling in prostate cancer cells. Biofactors 2006, 28, 159-168.
28. Hsu, Y.L.; Kuo, P.L.; Lin, L.T.; Lin, C.C. Isoliquiritigenin inhibits cell proliferation and induces apoptosis in human hepatoma cells. Planta Med. 2005, 71, 130-134.
29. Wang, K.L.; Hsia, S.M.; Chan, C.J.; Chang, F.Y.; Huang, C.Y.; Bau, D.T.; Wang, P.S. Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells. Expert Opin. Ther. Targets 2013, 17, 337-349.
30. Yamazaki, S.; Morita, T.; Endo, H.; Hamamoto, T.; Baba, M.; Joichi, Y.; Kaneko, S.; Okada, Y.; Okuyama, T.; Nishino, H.; et al. Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma. Cancer Lett. 2002, 183, 23-30.
31. Li, D.; Wang, Z.; Chen, H.; Wang, J.; Zheng, Q.; Shang, J.; Li, J. Isoliquiritigenin induces monocytic differentiation of HL-60 cells. Free Radic. Biol. Med. 2009, 46, 731-736.
32. Chen, H.; Zhang, B.; Yao, Y.; Chen, N.; Chen, X.; Tian, H.; Wang, Z.; Zheng, Q. NADPH oxidase-derived reactive oxygen species are involved in the HL-60 cell monocytic differentiation induced by isoliquiritigenin. Molecules 2012, 17, 13424-13438.
33. Chen, X.; Zhang, B.; Yuan, X.; Yang, F.; Liu, J.; Zhao, H.; Liu, L.; Wang, Y.; Wang Z.; Zheng, Q. Isoliquiritigenin-induced differentiation in mouse melanoma B16F0 cell line. Oxid. Med. Cell Longev. 2012, 2012, 534934.
34. Yuan, X.; Zhang, B.; Chen, N.; Chen, X.Y.; Liu, L.L.; Zheng, Q.S.; Wang, Z.P. Isoliquiritigenin treatment induces apoptosis by increasing intracellular ROS levels in HeLa cells. J. Asian Nat. Prod. Res. 2012, 14, 789-798.
35. Yuan, X.; Zhang, B.; Gan, L.; Wang, Z.H.; Yu, B.C.; Liu, L.L.; Zheng, Q.S.; Wang, Z.P. Involvement of the Mitochondrion-dependent and the endoplasmic reticulum stress-signaling pathways in isoliquiritigenin-induced apoptosis of HeLa Cell. Biomed. Environ. Sci. 2013, 26, 268-276.
36. Yuan, X.; Yu, B.; Wang, Y.; Jiang, J.; Liu, L.; Zhao, H.; Qi, W.; Zheng, Q. Involvement of endoplasmic reticulum stress in isoliquiritigenin-induced SKOV-3 cell apoptosis. Recent Pat. Anticancer Drug Discov. 2013, 8, 191-199.
37. Yuan, X.; Li, D.; Chen, H.; Sun, C.; Chen, N.; Wang, Z.; Zheng, Q. Isoliquiritigen Enhances Antitumour Activity of Cyclophosphamid. In Proceedings of the 2010 International Conference on Bioinformatics and Biomedical Technology, Chengdu, China, 18-20 June 2010; pp. 170-173.
38. Kaldor, J.M.; Day, N.E.; Clarke, E.A.; van Leeuwen, F.E.; Henry-Amar, M.; Fiorentino, M.V.; Bell, J.; Pedersen, D.; Band, P.; Assouline, D.; et al. Leukemia following Hodgkin's disease. N. Engl. J. Med. 1990, 322, 7-13.
39. Levine, E.G.; Bloomfield, C.D. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin. Oncol. 1992, 19, 47-84.
40. Yokoyama, Y.; Futagami, M.; Fukushi, Y.; Sakamoto, T.; Higuchi, T.; Fujii, S.; Sato, S.; Takami, H.; Saito, Y. Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin, and cyclophosphamide for stage IV epithelial ovarian cancer. Arch. Gynecol. Obstet. 2000, 263, 206-207.
41. Agarwala, S.; Hemal, A.K.; Seth, A.; Gupta, A.K.; Bhatnagar, V.; Mitra, D.K. Transitional cell carcinoma of the urinary bladder following exposure to cyclophosphamide in childhood. Eur. J. Pediatr. Surg. 2001, 11, 207-210.
42. Heller, A.; Trifonov, V.; Rubtsov, N.; Sauerbrey, A.; Starke, H.; Loncarevic, I.F.; Claussen, U.; Liehr, T. Complex chromosomal rearrangements in a secondary acute myeloblastic leukemia after chemotherapy in TRAPS. Oncol. Rep. 2003, 10, 1789-1792..
43. Habs, M.R.; Schmahl, D. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna). Cancer 1983, 51, 606-609.
44. Jenderny, J.; Walk, R.A.; Hackenberg, U.; Rohrborn, G. Chromosomal abnormalities and sister-chromatid exchange in bone marrow cells of mice and Chinese hamsters after inhalation and intraperitoneal administration. II. Cyclophosphamide. Mutat. Res. 1988, 203, 1-10.
45. Agrawal, R.C.; Kumar, S. Prevention of cyclophosphamide-induced micronucleus formation in mouse bone marrow by indole-3-carbinol. Food Chem. Toxicol. 1998, 36, 975-977.
46. Ozcan, A.; Korkmaz, A.; Oter, S.; Coskun, O. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats. Arch. Toxicol. 2005, 79, 461-465.
47. Lee, C.K.; Son, S.H.; Park, K.K.; Park, J.H.; Lim, S.S.; Chung, W.Y. Isoliquiritigenin inhibits tumor growth and protects the kidney and liver against chemotherapy-induced toxicity in a mouse xenograft model of colon carcinoma. J. Pharmacol. Sci. 2008, 106, 444-451.
48. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
49. Yallapu, M.M.; Maher, D.M.; Sundram, V.; Bell, M.C.; Jaggi, M.; Chauhan, S.C. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J. Ovarian. Res. 2010, doi:10.1186/1757-2215-3-11.
50. Tinwell, H.; Ashby, J. Comparison of acridine orange and Giemsa stains in several mouse bone marrow micronucleus assays - Including a triple dose study. Mutagenesis 1989, 4, 476-481.
51. Wang, Z.; Zheng, Q.; Liu, K.; Li, G.; Zheng, R. Ginsenoside Rh(2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide. Basic Clin. Pharmacol. Toxicol. 2006, 98, 411-415.
52. Konca, K.; Lankoff, A.; Banasik, A.; Lisowska, H.; Kuszewski, T.; Gozdz, S.; Koza, Z.; Wojcik, A. A cross-platform public domain PC image-analysis program for the comet assay. Mutat. Res. 2003, 534, 15-20.